EPIDERMAL GROWTH FACTOR RECEPTOR
Clinical trials for EPIDERMAL GROWTH FACTOR RECEPTOR explained in plain language.
Never miss a new study
Get alerted when new EPIDERMAL GROWTH FACTOR RECEPTOR trials appear
Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can surgery or radiation boost control of advanced lung cancer after First-Line combo therapy?
Disease control Recruiting nowThis study looks at whether adding surgery or radiation to the main lung tumor helps people with advanced EGFR-mutant lung cancer who already responded to initial treatment with osimertinib plus chemotherapy. About 70 adults will receive local therapy and be followed to see how l…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Pusan National University Hospital • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New hope for lung cancer patients with brain spread after standard treatment fails
Disease control Recruiting nowThis study tests a new treatment for people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the lining of the brain and spinal cord (leptomeningeal metastasis) and has stopped responding to the drug osimertinib. The treatment combin…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New drug EPI-326 enters human testing for tough cancers
Disease control Recruiting nowThis early-stage study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head and neck cancer. The main goal is to find a safe dose and check for side effects. Researchers will also measure drug levels in the blood…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Scientists test new scan to unlock secrets of aggressive brain tumors
Knowledge-focused Recruiting nowThis study is testing a new combined MRI and PET scan to measure how brain tumors use energy. Researchers will compare scan results with tissue samples from 50 adults with glioblastoma who need surgery. The goal is to improve imaging, not to treat the disease directly.
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 00:50 UTC